| Title : Rivastigmine for dementia associated with Parkinson's disease - Emre_2004_N.Engl.J.Med_351_2509 |
| Author(s) : Emre M , Aarsland D , Albanese A , Byrne EJ , Deuschl G , De Deyn PP , Durif F , Kulisevsky J , van Laar T , Lees A , Poewe W , Robillard A , Rosa MM , Wolters E , Quarg P , Tekin S , Lane R |
| Ref : N Engl J Med , 351 :2509 , 2004 |
| Abstract : Emre_2004_N.Engl.J.Med_351_2509 |
| ESTHER : Emre_2004_N.Engl.J.Med_351_2509 |
| PubMedSearch : Emre_2004_N.Engl.J.Med_351_2509 |
| PubMedID: 15590953 |
| Title : Potential treatment effects of donepezil not detected in Alzheimer's disease clinical trials: a physician survey - Rockwood_2004_Int.J.Geriatr.Psychiatry_19_954 |
| Author(s) : Rockwood K , Black SE , Robillard A , Lussier I |
| Ref : Int J Geriatr Psychiatry , 19 :954 , 2004 |
| Abstract : Rockwood_2004_Int.J.Geriatr.Psychiatry_19_954 |
| ESTHER : Rockwood_2004_Int.J.Geriatr.Psychiatry_19_954 |
| PubMedSearch : Rockwood_2004_Int.J.Geriatr.Psychiatry_19_954 |
| PubMedID: 15449367 |
| Title : Canadian Outcomes Study in Dementia: study methods and patient characteristics - Sambrook_2004_Can.J.Psychiatry_49_417 |
| Author(s) : Sambrook R , Herrmann N , Hebert R , McCracken P , Robillard A , Luong D , Yu A |
| Ref : Can J Psychiatry , 49 :417 , 2004 |
| Abstract : Sambrook_2004_Can.J.Psychiatry_49_417 |
| ESTHER : Sambrook_2004_Can.J.Psychiatry_49_417 |
| PubMedSearch : Sambrook_2004_Can.J.Psychiatry_49_417 |
| PubMedID: 15362245 |
| Title : Effects of washout and dose-escalation periods on the efficacy, safety, and tolerability of galantamine in patients previously treated with donepezil: ongoing clinical trials - Rasmusen_2001_Clin.Ther_23 Suppl A_A25 |
| Author(s) : Rasmusen L , Yan B , Robillard A , Dunbar F |
| Ref : Clin Ther , 23 Suppl A :A25 , 2001 |
| Abstract : Rasmusen_2001_Clin.Ther_23 Suppl A_A25 |
| ESTHER : Rasmusen_2001_Clin.Ther_23 Suppl A_A25 |
| PubMedSearch : Rasmusen_2001_Clin.Ther_23 Suppl A_A25 |
| PubMedID: 11396868 |
| Title : Rivastigmine for Alzheimer's disease: Canadian interpretation of intermediate outcome measures and cost implications - Baladi_2000_Clin.Ther_22_1549 |
| Author(s) : Baladi JF , Bailey PA , Black S , Bouchard RW , Farcnik KD , Gauthier S , Kertesz A , Mohr E , Robillard A |
| Ref : Clin Ther , 22 :1549 , 2000 |
| Abstract : Baladi_2000_Clin.Ther_22_1549 |
| ESTHER : Baladi_2000_Clin.Ther_22_1549 |
| PubMedSearch : Baladi_2000_Clin.Ther_22_1549 |
| PubMedID: 11192146 |